Latest news from the EMCDDA

Guide on responding to drug problems

24.10.2017 - How to respond to the problems of older heroin users? How to tackle deaths from highly potent fentanils? How to prevent harms from drug and alcohol use in festivals and clubs? These are among the questions explored by a new European guide released by the EMCDDA. Drawing on insights from 30 countries, Health and social responses to drug problems: a European guide presents the agency's first overview of actions and interventions currently available to address the consequences of illicit drug use. It is designed to benefit those approaching drug problems from a public health planning perspective as well as frontline workers and practitioners.

spacer3.jpg

Drug supply monitoring

07.12.2017 - The EMCDDA presents in a new paper its current thinking on the conceptual framework for monitoring drug markets, crime and supply reduction.

Drugs and the darknet

28.11.2017 - The EMCDDA and Europol present the latest understanding of how darknet markets function, the threats they pose to health and security and how Europe can respond.

Drug testing in schools

22.11.2017 - This EMCDDA paper (17 p.) evaluates the effectiveness of random testing in schools, based on studies conducted students aged 13 to 19 years, in the United States.

 Books3.jpg


The EMCDDA provide on its website a database on which you can search publications of interest by publication series, publication type, date, and keywords.

 

 

 

 

 

 

 

 

 

 

Quick access to the EMCDDA main publications archives

Drugs in Europe


2017 EMCDDA European Drug Report

miniEDR2017EN.jpgWhat do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.

  Country drug reports 2017

miniCountryProfiles.jpgDeveloped by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.